"Annual Achieving Clinical Regulatory Excellence Turkey Middle East" Channels RSS

22:53 EST 23rd November 2014 | BioPortfolio

BioPortfolio's Channels offers visitors a single point of access to life science and healthcare subjects, technologies, products and services. For example ImmTAC developed by Immunocore, PolyXen developed by Xenetic Biosciences. Each dedicated Channel web page provides highly specific information sourced from BioPortfolio's unique collection of databases - news stories, corporate directory, clinical trials, medical and scientific information.

Organizations can request specific channel pages to be created to promote their products, technologies, research tools and services. BioPortfolio makes a nominal charge of between $40 to $50 per web page published. Each bespoke Channel page is managed by the registered member who can edit and amend over the 12 month subscription period. To start publishing content on BioPortfolio's Channels open http://www.bioportfolio.net/report/23346-biochannel-publish-content-on-products-technologies.html

Interested? Contact priority@bioportfolio.com

Showing "Annual Achieving Clinical Regulatory Excellence Turkey Middle East" Channels 1–25 of 53

Relevant

Middle East

The Middle East has a wealth of biotechnology companies and is an important player in the global biotechnology industry. Following a World Summit on the Information Society, Arab countries are striving to build knowledge economies and societies; this i...

Regulatory factors

Regulatory Mechanisms

Oxford

Located in south-east England, Oxford is home to a world-famous academic institution, Oxford University, but is addition to this it hosts over 100 high-quality biotechnology companies with in 10 miles of the city, and is part of a south-east England regi...

Pfizer

Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...

Probably Relevant

Massachusetts

Located in the north-east corner of the USA, Massachusetts, has the third highest GDP of any state in America and is also a hotspot for the biotechnology industry. In addition to the globally renowned MIT, many other academic institutions and companies c...

Tuberculosis Vaccines and Therapeutics

The WHO estimates that the largest number of new tuberculosis (TB) cases in 2008 occurred in the South-East Asia Region, which accounted for 34% of incident cases globally. However, the estimated incidence rate in sub-Saharan Africa is nearly twice that of...

Johnson and Johnson

Johnson & Johnson is a leading pharmaceutical and healthcare company, with annual sales in 2009 of $22,520 million, ranking it the 8th largest pharmaceutical company in the world (based on sales). Medical and Diagnostic devices is a large interest ...

Connecticut

Connecticut, a state in the north-east corner of the US is a hub for biotechnology companies. There are over 100 high-quality companies with global markets based in Connecticut. In 2004, Connecticut boasted had 5.6 million square feet of laboratory spa...

Seroquel

Seroquel, an atypical antipsychotic medication has annual sales of $3.1m (in 2009), and based on annual sales, ranks 5th in the world. It is produced by AstraZeneca Pharmaceuticals as a quetiapine fumarate.  It is recommended for bipolar disorder ...

Hepatitis C

Most hepatitis C virus (HCV) infected individuals seeking treatment are chronically infected. Treatment goal is to achieve a sustained virological response (SVR), which is the absence of serum HCV RNA up to 6 months after therapy is concluded. To increas...

Abilify

Abilify (Aripiprazole) is an atypical antipsychotic produced by Bristol-Myers Squibb Company, with annual sales of $3m, ranking it 6th in the world for annual sales.  Abilify is prescribed in addition to other anti-depressants for the treatment of...

Boehringer Ingelheim

Boehringer Ingelheim is a global pharmaceutical company with annual sales of over $16 billion, making it the 10th largest pharmaceutical company in the world based on sales.  With bases in 47 companies, it has 41,000 employees and spends 20% of its ...

ImmTAC

Immunocore’s ImmTAC technology enables the immune system to recognise and kill cancer or viral cells. T Cell Receptors naturally recognise diseased cells and Immunocore’s competitive advantage is its ability to engineer high affinity T Cell ...

Plavix

Plavix is a clot-busting drug, produced by Bristol-Myers Squibb Company, and reached annual sales in 2009 of $4.2m, making the third highest drug in the world (based on 2009 annual sales). Prescriptions for Plavix are intended to lower a patients risk ...

Medtronic

With annual sales reaching $15 billion in 2010, Medtronic is the 4th largest medical devices company in the world (based on annual sales). The device portfolio of Medtronic is broad; covering cardiovascular stents, defibrillators and pacemakers, diabet...

Sanofi-Aventis

Sanofi-Aventis is a global pharmaceutical company with annual sales of $40,871m, placing it the second highest in the world. Although Sanofi-Aventis products are for a a very wide range of health problems, their major products are those for diabetes, o...

Scotland

With the United Kingdom, Scotland represents a long-standing center of biotechnological excellence, ranked in the top 5 in the world. Over the years, the following important developments have occurred in Scotland; penicillin, anaesthesia, CAT and MRI sca...

Michigan

Surrounded by the Great Lakes in the north east of the US, Michigan hosts many high profile biotechnology companies and has become an industry hotbed. In 1993 MichBio was formed, as an industry trade association, and drives the growth of the industry i...

The Scott Partnership

One of the leading business-to-business PR companies worldwide, The Scott Partnership has grown every year since inception and is continuing its expansion.with a global strategy, allowing international representation for clients needing global or loca...

Trigeminal Neuralgia

Trigeminal Neuralgia (TN) is an extremely severe facial pain that tends to come and go unpredictably in sudden shock-like attacks. The pain is often described as stabbing, shooting, excruciating, burning, extremely strong. The pain usually lasts for a fe...

Clinical Trials Phase News

Clinical trials involving new drugs are commonly classified into four phases. Each phase of the drug approval process is treated as a separate clinical trial. The drug-development process will normally proceed through all four phases over many years. If ...

Singulair

Singulair, the brand name for montelukast sodium, is produced by Merck & Co., Inc. Its annual sales in 2009 were $3m, ranking it 7th in the world. Singulair acts by blocking leukotrienes, to reduce to reaction of the body to allergic substances. It...

Possibly Relevant

T lymphocyte receptor CD3

CD3 is a T lymphocyte receptor involved in normal cell signaling. Antagonists of CD3 are thought to work by blocking the function of T effector cells that attack the body’s tissues and cause autoimmune disease while inducing a subset of T cells known...

Huntington's Disease

Huntington's disease is a hereditary disease caused by a defect in a single gene on Chromosome 4 that is inherited in an autosomal dominant fashion. The defect causes a part of DNA, called a CAG repeat, to occur many more times than it is supposed to...


Search BioPortfolio:
Loading
Advertisement
Advertisement

Channels Quicklinks